145 related articles for article (PubMed ID: 19449179)
1. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression.
Sakai S; Takaishi H; Matsuzaki K; Kaneko H; Furukawa M; Miyauchi Y; Shiraishi A; Saito K; Tanaka A; Taniguchi T; Suda T; Miyamoto T; Toyama Y
J Bone Miner Metab; 2009; 27(6):643-52. PubMed ID: 19449179
[TBL] [Abstract][Full Text] [Related]
2. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells.
Nagasawa T; Arai M; Togari A
Arch Oral Biol; 2011 Sep; 56(9):924-31. PubMed ID: 21377143
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
Cao B; Dai X; Wang W
J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
[TBL] [Abstract][Full Text] [Related]
5. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
6. Ethyl Acetate Fraction of Aqueous Extract of Lentinula edodes Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression.
Lee H; Lee K; Lee S; Lee J; Jeong WT; Lim HB; Hyun TK; Yi SJ; Kim K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079267
[TBL] [Abstract][Full Text] [Related]
7. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
Tsuji-Naito K
Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
[TBL] [Abstract][Full Text] [Related]
8. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.
Hasegawa H; Kido S; Tomomura M; Fujimoto K; Ohi M; Kiyomura M; Kanegae H; Inaba A; Sakagami H; Tomomura A
J Biol Chem; 2010 Aug; 285(33):25448-57. PubMed ID: 20547767
[TBL] [Abstract][Full Text] [Related]
9. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
13. Autophagy exerts pivotal roles in regulatory effects of 1α,25-(OH)
Ji L; Gao J; Kong R; Gao Y; Ji X; Zhao D
Biochem Biophys Res Commun; 2019 Apr; 511(4):869-874. PubMed ID: 30850163
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1α,25-(OH)2D3 on the formation and activity of osteoclasts in RAW264.7 cells.
Gu J; Tong XS; Chen GH; Wang D; Chen Y; Yuan Y; Liu XZ; Bian JC; Liu ZP
J Steroid Biochem Mol Biol; 2015 Aug; 152():25-33. PubMed ID: 25864627
[TBL] [Abstract][Full Text] [Related]
17. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
[TBL] [Abstract][Full Text] [Related]
18. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
19. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 Contributes to the Inhibitory Effect of lα,25-(OH)
Gu J; Zhang X; Zhang C; Li Y; Bian J; Liu X; Yuan Y; Zou H; Tong X; Liu Z
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]